reports
MAISONS DU MONDE: ANNUAL RESULTS 2024 IN LINE WITH GUIDANCE: Positive ...
MAISONS DU MONDE: ANNUAL RESULTS 2024 IN LINE WITH GUIDANCE: Positive free cash flow / Net Sales € 1.002 billion / Visible effects of Inspire Everyday expected in 2025, with a gradual return to growth PRESS RELEASENantes, March 11, 2025 ANNUAL RESULTS 2024 IN LINE WITH GUIDANCE: Positive free cash flow Net Sales € 1.002 billion Visible effects of Inspire Everyday expected in 2025, with a gradual return to growth 2024 Highlights Generated free cash flow (FCF) of €15m driven by strict control of working capital requirements (WCR) and by €45m in cost savings, despite lower turnover ...
MAISONS DU MONDE: RESULTAT ANNUEL 2024 EN LIGNE AVEC LA GUIDANCE: Free...
MAISONS DU MONDE: RESULTAT ANNUEL 2024 EN LIGNE AVEC LA GUIDANCE: Free cash-flow positif / Chiffre d’affaires de 1,002 milliard d’euros / Effets visibles de Inspire Everyday pour 2025 avec un retour progressif à la croissance COMMUNIQUE DE PRESSENantes, le 11 mars 2025 RESULTAT ANNUEL 2024 EN LIGNE AVEC LA GUIDANCE : Free cash-flow positif Chiffre d’affaires de 1,002 milliard d’euros Effets visibles de Inspire Everyday pour 2025 avec un retour progressif à la croissance Points clefs 2024 Génération d'un flux de trésorerie disponible (FCF) de 15 millions d'euros portée par une maît...
Kuros Biosciences grows sales to CHF 75.6 million for 2024
Kuros Biosciences grows sales to CHF 75.6 million for 2024 Ad-hoc announcement pursuant to Article 53 of the SIX listing rules Kuros Biosciences grows sales to CHF 75.6 million for 2024 Financial Highlights Direct MagnetOs™ sales increased by 136% to CHF 74.8 million (2023: CHF 31.7 million)Total Medical Device sales rose by 125% to CHF 75.6 million (2023: CHF 33.6 million)Total Group EBITDA reached CHF 2.2 million (2023: EBITDA loss of CHF (5.9) million), including the impairment, the group ended in a net loss of CHF (4.3) millionTotal Group adjusted EBITDA amounted to CHF 9.0 millio...
Curatis Announces Formation of Distinguished Advisory Board
LIESTAL, Switzerland--(BUSINESS WIRE)-- Curatis Holding (SIX:CURN) announces today the formation of an Advisory Board comprised of four internationally recognized experts across multiple medical and scientific disciplines. The board brings together leaders in pediatric oncology, neurology, drug development, and biochemistry to guide Curatis's research initiatives and strategic direction. "We are honored to welcome these distinguished experts to our Advisory Board," says Roland Rutschmann, CEO of Curatis. "Their collective expertise will be invaluable as we work to accelerate innovation and de...
Kakao Corp: 7 directors
Seven Directors at Kakao Corp bought 3,474 shares at between 43,087.376KRW and 44,000.000KRW. The significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ove...
Commercial International Bank (Egypt) CIB: 1 director
A director at Commercial International Bank (Egypt) CIB sold 18,872 shares at 0.000EGP and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over t...
Campus Activewear Ltd: 1 director
A director at Campus Activewear Ltd sold 5,000,000 shares at 258.500INR and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two yea...
Moody's Ratings assigns provisional ratings to Absolute Master 2503 ba...
2025 年3月11日、 東京、 ムーディーズSFジャパン株式会社（ 以下「ムーディーズ」） は、 下記案件 の予備格付付与を公表した。 本邦法令上の格付付与日は2025年3月10日である。. クラス、 予定配当率／ 利率、 格付 シリーズ2503優先受益権、 固定、 Aaa シリーズ2503 ABL、 固定、 Aaa. シリーズ2503発行総額： 251 億円 発行日： 2025 年3月31日 最終償還期日： 2035...
Moody's Ratings assigns provisional ratings to Absolute Master 2503 ba...
Moody's Ratings (Moody's) has assigned provisional ratings to the following transaction. The complete rating action is as follows: Transaction Name: Absolute Master 2503 Class, Scheduled Dividend/Interest Rate, Rating Class I Series2503 Senior Beneficial Interests, Fixed, (P)Aaa (sf) Series25...
EQS-News: Aufbauend auf dem Erfolg von 2024, erwartet Redcare Pharmacy...
EQS-News: Redcare Pharmacy N.V. / Schlagwort(e): Jahresergebnis/Prognose Aufbauend auf dem Erfolg von 2024, erwartet Redcare Pharmacy 2025 eine Margensteigerung und weiteres starkes Wachstum – inklusive einer Verdopplung des Rx-Umsatzes. 11.03.2025 / 06:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Aufbauend auf dem Erfolg von 2024, erwartet Redcare Pharmacy 2025 eine Margensteigerung und weiteres starkes Wachstum – inklusive einer Verdopplung des Rx-Umsatzes. Konzernumsatz wächst 2024 um 32% auf EUR 2,4 Mrd. (Q4: +27%), mit DAC...
EQS-News: Building on a successful 2024, Redcare Pharmacy expects marg...
EQS-News: Redcare Pharmacy N.V. / Key word(s): Annual Results/Forecast Building on a successful 2024, Redcare Pharmacy expects margin uplift and unabated fast growth in 2025, including a doubling of Rx. 11.03.2025 / 06:30 CET/CEST The issuer is solely responsible for the content of this announcement. Building on a successful 2024, Redcare Pharmacy expects margin uplift and unabated fast growth in 2025, including a doubling of Rx. Total sales +32% to EUR 2.4 bn in FY 2024 (Q4, +27%), with DACH +33% (Q4, 27%) and International +26% (Q4, 29%). Non-Rx sales +21% to EUR 1.6 b...
Comprehensive Leasing Co: 1 director
A director at Comprehensive Leasing Co sold 115,032 shares at 0.000JOD and the significance rating of the trade was 77/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...
Ancara Logistics Indonesia Tbk PT: 1 director
A director at Ancara Logistics Indonesia Tbk PT sold 16,850,000 shares at 374.534IDR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the...
ClearView Wealth Ltd: 2 directors
Two Directors at ClearView Wealth Ltd bought 495,821 shares at between 0.440AUD and 0.455AUD. The significance rating of the trade was 74/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ove...
Doosan Enerbility Co Ltd: 47 directors
Twenty-three Directors at Doosan Enerbility Co Ltd bought/maiden bought 36,903 shares at between 25,500.000KRW and 26,800.000KRW. The significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trade...
Assessment Framework: Second Party Opinions on Sustainable Debt
This assessment framework describes our approach to second party opinions on sustainable debt.
Capcom annonce un partenariat avec la Coupe du monde de l’e-sport
OSAKA, Japon--(BUSINESS WIRE)-- Capcom Co., Ltd. (TOKYO : 9697) (Capcom) a annoncé aujourd’hui un partenariat de trois ans avec la Coupe du monde de l’e-sport (Esports World Cup, EWC) de l’Esports World Cup Foundation, qui se tient en Arabie Saoudite, dans le cadre de l’initiative liée aux sports électroniques de l’entreprise. Ce communiqué de presse contient des éléments multimédias. Voir le communiqué complet ici : Street Fighter 6/EWC Collaboration (Graphic: Business Wire) Dans le cadre d’un projet national de l’Arabie saoudite, la première édition de l’EWC a rassemblé l’an dernier 1 500 jo...
- Ian Wong
- Jayanth Kandalam
- Peter Low
Lucror Analytics - Morning Views Europe
In today's Morning Views publication we comment on developments of the following high yield issuers: Kantar, Air Baltic, Loxam, Hapag-Lloyd
Nanosonics Limited: 1 director
A director at Nanosonics Limited maiden bought 20,000 shares at 4.357AUD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...
Transdigm Group Inc: 1 director
Two Directors at Transdigm Group Inc sold 80,006 shares at between 0.000USD and 1,343.427USD. The significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ove...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.